Third View Private Wealth »

Regeneron Pharmaceuticals shares owned by Third View Private Wealth

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Third View Private Wealth from 13F filings

Historical chart of Third View Private Wealth investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Third View Private Wealth consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Third View Private Wealth

Quarter filed Position value Share count Share price at filing
2025-12-31 $5.5M 7.1k 771.87

More positions owned by Third View Private Wealth

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Meta Platforms Cl A (META)
Amazon (AMZN)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Visa Com Cl A (V)
Apple (AAPL)
Alphabet Cap Stk Cl C (GOOG)
Oracle Corporation (ORCL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Netflix (NFLX)
Vanguard Index Fds Growth Etf (VUG)
Boeing Company (BA)

View all positions for Third View Private Wealth

Top funds holding Regeneron Pharmaceuticals

Vanguard Group
BlackRock
State Street Corporation
Dodge & Cox
Jpmorgan Chase & Co
Geode Capital Management
Franklin Resources
Capital World Investors
Loomis, Sayles and
FMR
Invesco
Susquehanna International
Goldman Sachs Group
Nuveen
Northern Trust

View all funds holding Regeneron Pharmaceuticals